Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Taylor Thompson

Showing results (221-230 of 269) with videos related to

Pageof 27
Sort By:
JAMA Network Open|February 14, 2023
Assessment of Symptom, Disability, and Financial Trajectories in Patients Hospitalized for COVID-19 at 6 MonthsAndrew J Admon, Theodore J Iwashyna, Lee A Kamphuis, et al.
Intensive Care Medicine|November 16, 2017
Correction to: Potentially modifiable factors contributing to outcome from acute respiratory distress syndrome: the LUNG SAFE studyJohn G Laffey, Giacomo Bellani, Tài Pham, et al.
The Lancet. Respiratory Medicine|November 21, 2018
Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (START study): a randomised phase 2a safety trialMichael A Matthay, Carolyn S Calfee, Hanjing Zhuo, et al.
Intensive Care Medicine|October 21, 2016
Potentially modifiable factors contributing to outcome from acute respiratory distress syndrome: the LUNG SAFE studyJohn G Laffey, Giacomo Bellani, Tài Pham, et al.
Journal of Medical Genetics|October 11, 2012
Distinct and replicable genetic risk factors for acute respiratory distress syndrome of pulmonary or extrapulmonary originPaula Tejera, Nuala J Meyer, Feng Chen, et al.
Chest|May 3, 2022
Oxygen-Free Days as an Outcome Measure in Clinical Trials of Therapies for COVID-19 and Other Causes of New-Onset HypoxemiaAri Moskowitz, Matthew S Shotwell, Kevin W Gibbs, et al.
The Lancet. Respiratory Medicine|July 26, 2021
Advancing precision medicine for acute respiratory distress syndromeJeremy R Beitler, B Taylor Thompson, Rebecca M Baron, et al.
Intensive Care Medicine|December 7, 2007
Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008R Phillip Dellinger, Mitchell M Levy, Jean M Carlet, et al.
The Lancet. Respiratory Medicine|February 28, 2025
Perioperative lung expansion and pulmonary outcomes after open abdominal surgery versus usual care in the USA (PRIME-AIR): a multicentre, randomised, controlled, phase 3 trialAna Fernandez-Bustamante, Robert A Parker, Gyorgy Frendl, et al.
Sleep & Breathing = Schlaf & Atmung|August 15, 2022
High prevalence of sleep-disordered breathing in the intensive care unit - a cross-sectional studyAbigail A Bucklin, Wolfgang Ganglberger, Syed A Quadri, et al.
Pageof 27

Showing results (221-230 of 269) with videos related to

Sort By:
Pageof 27
JAMA Network Open|February 14, 2023
Assessment of Symptom, Disability, and Financial Trajectories in Patients Hospitalized for COVID-19 at 6 MonthsAndrew J Admon, Theodore J Iwashyna, Lee A Kamphuis, et al.
Intensive Care Medicine|November 16, 2017
Correction to: Potentially modifiable factors contributing to outcome from acute respiratory distress syndrome: the LUNG SAFE studyJohn G Laffey, Giacomo Bellani, Tài Pham, et al.
The Lancet. Respiratory Medicine|November 21, 2018
Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (START study): a randomised phase 2a safety trialMichael A Matthay, Carolyn S Calfee, Hanjing Zhuo, et al.
Intensive Care Medicine|October 21, 2016
Potentially modifiable factors contributing to outcome from acute respiratory distress syndrome: the LUNG SAFE studyJohn G Laffey, Giacomo Bellani, Tài Pham, et al.
Journal of Medical Genetics|October 11, 2012
Distinct and replicable genetic risk factors for acute respiratory distress syndrome of pulmonary or extrapulmonary originPaula Tejera, Nuala J Meyer, Feng Chen, et al.
Chest|May 3, 2022
Oxygen-Free Days as an Outcome Measure in Clinical Trials of Therapies for COVID-19 and Other Causes of New-Onset HypoxemiaAri Moskowitz, Matthew S Shotwell, Kevin W Gibbs, et al.
The Lancet. Respiratory Medicine|July 26, 2021
Advancing precision medicine for acute respiratory distress syndromeJeremy R Beitler, B Taylor Thompson, Rebecca M Baron, et al.
Intensive Care Medicine|December 7, 2007
Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008R Phillip Dellinger, Mitchell M Levy, Jean M Carlet, et al.
The Lancet. Respiratory Medicine|February 28, 2025
Perioperative lung expansion and pulmonary outcomes after open abdominal surgery versus usual care in the USA (PRIME-AIR): a multicentre, randomised, controlled, phase 3 trialAna Fernandez-Bustamante, Robert A Parker, Gyorgy Frendl, et al.
Sleep & Breathing = Schlaf & Atmung|August 15, 2022
High prevalence of sleep-disordered breathing in the intensive care unit - a cross-sectional studyAbigail A Bucklin, Wolfgang Ganglberger, Syed A Quadri, et al.
Pageof 27